학술논문

Methyl-beta-cyclodextrin induces programmed cell death in chronic myeloid leukemia cells and, combined with imatinib, produces a synergistic downregulation of ERK/SPK1 signaling
Document Type
Journal
Source
ANTI-CANCER DRUGS; JAN 2012, 23 1, p22-p31, 10p.
Subject
Language
English
ISSN
09594973